Back to Top
Vudalimab Biosimilar - Research Grade
Add recommended extras
Vudalimab Biosimilar - Research Grade
| Concentration | 5mg/ml |
|---|---|
| Isotype | Human IgG1 (N208D/E233P/L234V/L235A/G236Del/S267K/Q295E/L368D/K370S/N384D/Q418E/N421D/M428L/N434S)-Kappa |
| Host | CHO Cells |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Application Notes | This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients. |
| Applications | Functional Assays |
| Storage | This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C. |
| Endotoxin | <1EU/mg Determined by LAL gel clotting assay |
| Purity | >90% by SDS-PAGE |
| Formulation | 20mM His/Asp, pH 5.0,Contains no stabilizers or preservatives |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human PD-1 and human CTLA-4 |
| Species Reactivity | Human |
| Target | PD-1 + CTLA-4 |
| Shipping Conditions | Blue ice |
| background | Uses the same sequence as the therapeutic antibody Vudalimab |
| Buffer | ICH3002 |
| Sequence | https://www.imgt.org/mAb-DB/ |
Write Your Own Review
Who Viewed This Also Viewed
Iladatuzumab Vedotin Biosimilar - Research Grade
$700.00 - $3,024.00
Anti-CD86 (GL1) In Vivo Antibody - Low Endotoxin
$390.00 - $3,702.00
Mirvetuximab Vedotin Biosimilar - Research Grade
$700.00 - $3,024.00
